LBO — OVIEDO MEDICAL CENTER
IRR: 19.1% | MOIC: 2.40x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
19.1%
IRR
2.40x
MOIC
$84.1M
Entry EV
$139.7M
Exit EV
$43.3M
Equity Invested
Sources & Uses
S&UTotal · $84.1M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $32.7M | 38.8% | |
| Sub Debt | $8.2M | 9.7% | |
| Equity | $43.3M | 51.5% | |
| Enterprise Value | $81.6M | 97.1% | |
| Transaction Fees | $2.4M | 2.9% | |
| Total Uses | $84.1M | 100.0% |
Interpretation
INTAt 2.40x MOIC and 19.1% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $13.3M |
| Exit Ev | $139.7M |
| Net Debt At Exit | $35.9M |
| Equity At Exit | $103.8M |
| Equity Invested | $43.3M |
| Total Value Created | $60.6M |
| Value From Growth | $54.0M |
| Value From Multiple | $4.1M |
| Value From Deleveraging | $4.9M |